Cone-Beam CT Guided Localization for Lung Cancer
Trial Summary
What is the purpose of this trial?
The Guided Therapeutics (GTx) program at the University Health Network is a network of clinicians, scientists, and engineers focused on the development and translation of image-guided technologies focused on minimally-invasive, adaptive therapies. Technologies developed within the GTx program include a portable intra-operative cone-beam CT (in collaboration with Siemens) that has been evaluated in clinical trials for head and neck surgery. The intraoperative imaging has been integrated with tracking and navigational tools and optical imaging to provide a general "surgical dashboard" that is used to improve the accuracy of surgical resection. A recent addition to the GTx program is the development of the GTx OR, located within the general operating room of the Toronto General Hospital. The GTx OR houses 2 complimentary advance technologies: the Siemens Zeego and the Siemens Somotom Flash CT. The dual-energy Somatom Flash provides a "gold-standard" in CT imaging, while the Zeego provides excellent 3D Cone-beam CT with robotic placement for flexible integration within the operating environment. Together, the integration of these 2 components into a single OR enables critical evaluation of the limits of CT imaging technology for surgical guidance. This study will be conducted using solely the Cone-beam CT (Zeego) for percutaneous placement and localization of markers for resection of small pulmonary nodules during VATS.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Cone Beam CT Guided Localization for Lung Cancer?
Research shows that using cone-beam CT for guiding the placement of microcoils in lung cancer surgery helps accurately locate small lung nodules, making surgery safer and more comfortable for patients. This technique is effective in ensuring precise targeting, which can improve surgical outcomes.12345
Is Cone-Beam CT Guided Localization for Lung Cancer safe?
How is the Cone-Beam CT Guided Localization treatment for lung cancer different from other treatments?
This treatment uses cone-beam CT (a type of imaging technology) to guide the precise placement of a microcoil (a small wire) in the lung, which helps in accurately locating small lung nodules before surgery. This approach is unique because it enhances the accuracy of nodule localization while minimizing patient discomfort compared to traditional methods.12459
Eligibility Criteria
Adults over 18 with lung nodules set for microcoil localization before VATS wedge resection can join. Excluded are those who can't consent, tolerate anesthesia, pregnant individuals, patients with RF-sensitive implants, and severely obese patients.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Procedure
Cone-beam CT (Zeego) is used for percutaneous placement and localization of markers for resection of small pulmonary nodules during VATS
Follow-up
Participants are monitored for safety and effectiveness after the procedure
Treatment Details
Interventions
- Cone Beam CT localization and placement of microcoil
Cone Beam CT localization and placement of microcoil is already approved in United States, Canada, European Union for the following indications:
- Localization of small pulmonary nodules during VATS
- Localization of small pulmonary nodules during VATS
- Localization of small pulmonary nodules during VATS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor